{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:26:39Z","timestamp":1792661199067,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.ophtha.2011.01.041","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T20:58:40Z","timestamp":1299531520000},"page":"591-599","source":"Crossref","is-referenced-by-count":94,"title":["Horizons in Therapy for Corneal Angiogenesis"],"prefix":"10.1016","volume":"118","author":[{"given":"Surekha","family":"Maddula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don K.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Maddula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Burrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balamurali K.","family":"Ambati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2011.01.041_bib1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12041-009-0068-0","article-title":"Mediators of ocular angiogenesis","volume":"88","author":"Qazi","year":"2009","journal-title":"J Genet"},{"key":"10.1016\/j.ophtha.2011.01.041_bib2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","article-title":"Corneal avascularity is due to soluble VEGF receptor-1","volume":"443","author":"Ambati","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ophtha.2011.01.041_bib3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm.2018","article-title":"Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth","volume":"15","author":"Albuquerque","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.ophtha.2011.01.041_bib4","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.0506112103","article-title":"Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision","volume":"103","author":"Cursiefen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ophtha.2011.01.041_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00003226-200307000-00013","article-title":"Inhibition of corneal neovascularization by genetic ablation of CCR2","volume":"22","author":"Ambati","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2011.01.041_bib6","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1167\/iovs.02-0685","article-title":"Sustained inhibition of corneal neovascularization by genetic ablation of CCR5","volume":"44","author":"Ambati","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2011.01.041_bib7","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/bjo.2003.035071","article-title":"Photodynamic therapy for corneal neovascularisation and lipid degeneration","volume":"88","author":"Brooks","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.01.041_bib8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ajo.2005.11.003","article-title":"Argon laser photodynamic therapy of human corneal neovascularization after intravenous administration of dihematoporphyrin ether","volume":"141","author":"Sheppard","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.01.041_bib9","author":"Yoon"},{"key":"10.1016\/j.ophtha.2011.01.041_bib10","first-page":"330","article-title":"Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis)","volume":"105","author":"Dana","year":"2007","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2011.01.041_bib11","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1167\/iovs.08-2732","article-title":"Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist","volume":"50","author":"Lu","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2011.01.041_bib12","author":"Dana"},{"key":"10.1016\/j.ophtha.2011.01.041_bib13","first-page":"1461","article-title":"Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats","volume":"12","author":"Bourges","year":"2006","journal-title":"Mol Vis"},{"key":"10.1016\/j.ophtha.2011.01.041_bib15","first-page":"1138","article-title":"Autologous transplantation of conjunctival epithelial cells cultured on amniotic membrane in a rabbit model","volume":"13","author":"Ono","year":"2007","journal-title":"Mol Vis"},{"key":"10.1016\/j.ophtha.2011.01.041_bib16","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archopht.125.10.1337","article-title":"Phenotypic study after cultivated limbal epithelial transplantation for limbal stem cell deficiency","volume":"125","author":"Kawashima","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.01.041_bib17","author":"Zakaria"},{"key":"10.1016\/j.ophtha.2011.01.041_bib18","author":"Aghdami"},{"key":"10.1016\/j.ophtha.2011.01.041_bib19","author":"Raffiee"},{"key":"10.1016\/j.ophtha.2011.01.041_bib20","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/bjo.2007.130013","article-title":"Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy","volume":"92","author":"Yamada","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.01.041_bib21","author":"Chen"},{"key":"10.1016\/j.ophtha.2011.01.041_bib22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/ICO.0b013e3181605ff9","article-title":"Inhibition of experimental angiogenesis of cornea by various doses of doxycycline and combination of triamcinolone acetonide with low-molecular-weight heparin and doxycycline","volume":"27","author":"Aydin","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2011.01.041_bib23","author":"Kim"},{"key":"10.1016\/j.ophtha.2011.01.041_bib24","author":"Hsiao"},{"key":"10.1016\/j.ophtha.2011.01.041_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00417-005-0036-1","article-title":"Inhibitory effect of triamcinolone acetonide on corneal neovascularization","volume":"244","author":"Murata","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.01.041_bib26","author":"Dana"},{"key":"10.1016\/j.ophtha.2011.01.041_bib27","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/ICO.0b013e318180e50f","article-title":"Bevacizumab (Avastin) and argon laser to treat neovascularization in corneal transplant surgery","volume":"27","author":"Gerten","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2011.01.041_bib28","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11373-007-9153-7","article-title":"Inhibition of corneal neovascularization with endostatin delivered by adeno-associated viral (AAV) vector in a mouse corneal injury model","volume":"14","author":"Lai","year":"2007","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.ophtha.2011.01.041_bib29","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1167\/iovs.08-2462","article-title":"Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators","volume":"50","author":"Jin","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2011.01.041_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.arcmed.2008.10.004","article-title":"Inhibition of corneal neovascularization with propolis extract","volume":"40","author":"Keshavarz","year":"2009","journal-title":"Arch Med Res"},{"key":"10.1016\/j.ophtha.2011.01.041_bib31","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.lfs.2008.11.018","article-title":"Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7","volume":"84","author":"Sen","year":"2009","journal-title":"Life Sci"},{"key":"10.1016\/j.ophtha.2011.01.041_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.biopha.2005.06.001","article-title":"Effect of resveratrol on matrix metalloproteinase-2 (MMP-2) and Secreted Protein Acidic and Rich in Cysteine (SPARC) on human cultured glioblastoma cells","volume":"59","author":"Gagliano","year":"2005","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ophtha.2011.01.041_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10495-006-3558-z","article-title":"1,25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor","volume":"11","author":"Riachy","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.ophtha.2011.01.041_bib34","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.exer.2007.01.022","article-title":"Receptor tyrosine kinase inhibitors AG013764 and AG013711 reduce choroidal neovascularization in rat eye","volume":"84","author":"Wang","year":"2007","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2011.01.041_bib35","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1167\/iovs.03-0600","article-title":"Periocular injection of microspheres containing PKC412 inhibits choroidal neovascularization in a porcine model","volume":"44","author":"Saishin","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2011.01.041_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.exer.2009.09.022","article-title":"Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1\/2 and Akt","volume":"90","author":"Nakamura","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2011.01.041_bib37","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1021\/jm7011276","article-title":"Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-be nzotriazin-7-yl)phenyl benzoate (TG100801): a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration","volume":"51","author":"Palanki","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.ophtha.2011.01.041_bib38","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm1742","article-title":"Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability","volume":"14","author":"Jones","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.ophtha.2011.01.041_bib39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1200\/JCO.2009.22.9237","article-title":"Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors","volume":"28","author":"Lockhart","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ophtha.2011.01.041_bib40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/112067211002000106","article-title":"VEGF Trap(R1R2) suppresses experimental corneal angiogenesis","volume":"20","author":"Oliveira","year":"2010","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.01.041_bib41","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.gt.3301680","article-title":"Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1","volume":"9","author":"Bainbridge","year":"2002","journal-title":"Gene Ther"},{"key":"10.1016\/j.ophtha.2011.01.041_bib42","first-page":"75","article-title":"Prevention of diabetic retinopathy by intraocular soluble flt-1 gene transfer in a spontaneously diabetic rat model","volume":"19","author":"Ideno","year":"2007","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ophtha.2011.01.041_bib43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ymthe.2005.04.022","article-title":"Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys","volume":"12","author":"Lai","year":"2005","journal-title":"Mol Ther"},{"key":"10.1016\/j.ophtha.2011.01.041_bib44","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1089\/hum.2009.153","article-title":"Adeno-associated vector (type 8)-mediated expression of soluble Flt-1 efficiently inhibits neovascularization in a murine choroidal neovascularization model","volume":"21","author":"Igarashi","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.ophtha.2011.01.041_bib45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00417-007-0683-5","article-title":"Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation","volume":"246","author":"Bock","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2011.01.041_bib46","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1167\/iovs.06-0853","article-title":"Nanoparticles sustain expression of Flt intraceptors in the cornea and inhibit injury-induced corneal angiogenesis","volume":"48","author":"Jani","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2011.01.041_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/ICO.0b013e31802b4201","article-title":"Unique homologous siRNA blocks hypoxia-induced VEGF upregulation in human corneal cells and inhibits and regresses murine corneal neovascularization","volume":"26","author":"Singh","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2011.01.041_bib48","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature06765","article-title":"Sequence- and target-independent angiogenesis suppression by siRNA via TLR3","volume":"452","author":"Kleinman","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ophtha.2011.01.041_bib49","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1073\/pnas.0812317106","article-title":"Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth","volume":"106","author":"Cho","year":"2009","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011000753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642011000753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T02:10:02Z","timestamp":1637374202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642011000753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0161642011000753"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2011.01.041","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}